EP2815762

GLAXOSMITHKLINE
Application Number
EP14181075A
Filing Date
Mar 7, 2011
Status
Granted And Under Opposition
Apr 28, 2017
Grant Date
May 31, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP2815762B1 was granted to Glaxosmithkline on May 31, 2017 following the initial filing on Mar 7, 2011 under the application number EP14181075A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SANOFI PASTEUR INCSANOFI AVENTIS DEUTSCHLAND GMBHSANOFI WINTHROP INDUSTRIESFeb 28, 2018WITHDRAWN
SK CHEMICALSFeb 28, 2018WITHDRAWN
MERCK SHARP & DOHMEFeb 26, 2018WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents